Trailing-twelve-month (TTM) revenue is $4.22 Million with a year-over-year growth of +38.09%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $1,111,797 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q2 FY2026Period ended 2025-12-31 | $896,774 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q3 FY2026Period ended 2026-03-31 | $1,060,802 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q4 FY2026Period ended 2026-06-30 | $1,145,802 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-19 |
| TTM revenue | $4,215,175 |
Current P/S: $5,207,381 market capitalization ÷ $4,215,175 TTM revenue = 1.24x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:14:17.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $1.15M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:17:08.240Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD |
|---|---|---|---|
| Other Sales | $196,705 | $623,475 | $578,642 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|
| Americas | N/A | N/A | $22,638 | $8,750 |
| Asia Pacific | N/A | N/A | $41,576 | $12,467 |
| AUSTRALIA | $6,491 | $43,955 | N/A |
$4.22M
$4.22 Million
+38.09%
vs. $3.05M a year ago (TTM)
+19.95%
5 Year compound annual growth rate
1 Year
+38.09%
3 Year
+49.67%
5 Year
+19.95%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $4.22M | +$1.16M | +38.09% |
| 2025 | $3.05M | ($59,249) | (1.90%) |
| 2024 | $3.11M | +$1.85M | +147.58% |
| 2023 | $1.26M | ($723,612) | (36.54%) |
| 2021 | $1.98M | +$1.79M | +949.30% |
TTM Growth
+38.09%
3-Year CAGR
+49.67%
5-Year CAGR
+19.95%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:17:08.240Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| Other Country | $189,190 | $470,562 | $132,700 | $40,199 |
|---|
